Burdick Kenneth A 4

What Happened Kenneth A. Burdick, a director of LifeStance Health Group, had performance- and time-based restricted stock units vest on March 9, 2026. He was credited with 740,504 shares (33,544 PSUs + 706,960 PSUs/RSUs) at $0.00 (awarded), and the company withheld 327,209 shares to satisfy tax withholding obligations at $6.91 per share (three withholding entries totaling about $2.26M). After withholding, Burdick netted approximately 413,295 shares. The withheld shares were tax withholdings and do not represent open-market sales.

Key Details

• Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (timely filing).
• Awards acquired: 740,504 shares (33,544 and 706,960) at $0.00 — these were PSUs/RSUs that vested.
• Shares withheld for taxes (reported as disposals): 35,816; 13,201; and 278,192 at $6.91 — total value ≈ $2,261,015.
• Net new shares received after withholding: ~413,295.
• Footnotes: PSUs were previously granted on Mar 6, 2025 and Feb 27, 2025; withheld shares reflect net settlement for vested RSUs/PSUs (F1–F5).
• Shares owned after the transaction are not provided in the excerpt.

Context This was a vesting/settlement of equity awards (not an open-market purchase or sale). The disposals reported are routine tax-withholding by the issuer as part of net settlement and should not be read as insider selling into the market. For retail investors, award vesting increases insider ownership but doesn’t necessarily signal a change in sentiment.